全文获取类型
收费全文 | 37668篇 |
免费 | 2470篇 |
国内免费 | 859篇 |
专业分类
耳鼻咽喉 | 605篇 |
儿科学 | 1047篇 |
妇产科学 | 435篇 |
基础医学 | 4079篇 |
口腔科学 | 2282篇 |
临床医学 | 2860篇 |
内科学 | 3026篇 |
皮肤病学 | 188篇 |
神经病学 | 1134篇 |
特种医学 | 2725篇 |
外科学 | 13200篇 |
综合类 | 4181篇 |
预防医学 | 1159篇 |
眼科学 | 193篇 |
药学 | 1502篇 |
14篇 | |
中国医学 | 720篇 |
肿瘤学 | 1647篇 |
出版年
2024年 | 52篇 |
2023年 | 339篇 |
2022年 | 812篇 |
2021年 | 979篇 |
2020年 | 829篇 |
2019年 | 777篇 |
2018年 | 952篇 |
2017年 | 873篇 |
2016年 | 1119篇 |
2015年 | 1241篇 |
2014年 | 2143篇 |
2013年 | 2229篇 |
2012年 | 1868篇 |
2011年 | 2126篇 |
2010年 | 1844篇 |
2009年 | 2100篇 |
2008年 | 2061篇 |
2007年 | 2034篇 |
2006年 | 1977篇 |
2005年 | 1951篇 |
2004年 | 1589篇 |
2003年 | 1356篇 |
2002年 | 1007篇 |
2001年 | 924篇 |
2000年 | 930篇 |
1999年 | 777篇 |
1998年 | 643篇 |
1997年 | 633篇 |
1996年 | 525篇 |
1995年 | 499篇 |
1994年 | 429篇 |
1993年 | 383篇 |
1992年 | 327篇 |
1991年 | 289篇 |
1990年 | 259篇 |
1989年 | 209篇 |
1988年 | 209篇 |
1987年 | 184篇 |
1986年 | 183篇 |
1985年 | 201篇 |
1984年 | 153篇 |
1983年 | 76篇 |
1982年 | 137篇 |
1981年 | 118篇 |
1980年 | 106篇 |
1979年 | 120篇 |
1978年 | 85篇 |
1977年 | 81篇 |
1976年 | 53篇 |
1973年 | 43篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
F.-P. Tillmann M. Jäger D. Blondin D. Schooldermann A. Voiculescu C. Sucker B. Grabensee R. Krauspe G. R. Hetzel 《American journal of transplantation》2007,7(3):667-671
The purpose of this study was to investigate the application of intravenous iloprost as a novel therapy for the treatment of post-transplant distal limb syndrome (PTDLS). PTDLS is a benign but disabling complication in the first year after renal transplantation. It is characterized by bilateral, often incapacitating pain in the feet and or knees on motion and a significant rise in alkaline phosphatase levels on laboratory evaluation. On MRI, bone marrow edema of the affected bone regions can be demonstrated. PTDLS differs from steroid induced osteonecrosis of the hip in terms of localization, an average cumulative steroid dosage within expected limits, and a benign outcome, as PTDLS does not progress to overt cell necrosis. From August 2003 to April 2005 we treated 10 patients with MRI-proven diagnosis of PTDLS following a standardized regimen of intravenous iloprost over 5 days. Iloprost led to prompt pain relief measured on a visual analogous scale (VAS) ranging from 1 to 10 (5.6 +/- 1.5 before vs. 2.1 +/- 1.3 after treatment, p = 0.0004). PTDLS represents a benign but disabling complication following renal transplantation. Intravenous iloprost might be a promising therapeutic concept leading to a quick relief of symptoms without relevant side effects. 相似文献
22.
目的观察应用动力髁螺钉联合骨肽注射液治疗股骨髁上骨不连的疗效。方法53例股骨髁上骨不连患者随机分为两组:对照组(26例)和治疗组(27例),两组均应用动力髁螺钉治疗,治疗组加用骨肽注射液治疗。随访,进行疗效评价,记录骨愈合时间和测定疼痛指数。结果治疗组疗效优于对照组。结论应用动力髁螺钉联合骨肽注射液治疗股骨髁上骨不连可提高疗效。 相似文献
23.
骨髓基质干细胞修复兔关节软骨缺损的实验研究 总被引:1,自引:1,他引:0
目的研究以多聚乙醇酸(PGA)为支架的骨髓基质干细胞(BMSCs)复合物修复兔膝关节软骨缺损的情况。方法体外培养扩增的自体BMSCs种植于PGA支架并培养72h,然后将支架-细胞复合物植入兔关节软骨缺损模型。术后12周处死动物,标本行大体观察、组织学检查及Ⅱ型胶原免疫组化染色。结果BMSCs-PGA复合物植入后形成丰富的透明软骨样修复组织,新生软骨无明显退变。对照组主要为纤维组织及软骨下骨修复。结论BMSCs-PGA复合物可修复关节软骨缺损。 相似文献
24.
Abstract Surgical treatment of proximal humeral fractures still remains a challenge. This is primarily due to the fact that sufficient
implant fixation in humeral head fractures is often not achieved due to substantial bone tissue loss with increasing age.
In the last few years the locking plates and locking nails have been introduced into clinical practice with varying results.
The biomechanical studies have focused on locking plate osteosynthesis as well. The following paper focuses on bone quality,
biomechanical studies and biology of proper osteosynthesis and reviews the most recent literature. 相似文献
25.
神经化组织工程骨构建的初步观察 总被引:16,自引:0,他引:16
目的评估两种组织工程骨体内神经化重建方法的成骨效果,研究神经化与成骨的相互关系。方法26只新西兰大白兔,其中24只随机分成四组:组织工程骨组(A组),感觉神经束植入组(B组),运动神经束植入组(C组),血管束植入组(D组);另2只为空白对照组。每只动物均制备左侧股骨长1.5cm的段缺性骨与骨膜缺损,钢板固定后骨缺损处分别植入用四种方法制备的组织工程骨。植入的神经分别是隐神经和股神经肌支。术后4、8、12周摄股骨正位X线片,用放射影像学评分和X线阻射影分析比较骨缺损修复情况。结果在组织工程骨中植入感觉神经束后,比单纯组织工程骨和运动神经束植入的修复效果均有明显提高,而在组织工程骨中植入运动神经束与单纯组织工程骨修复骨缺损的效果相比较无明显差异,感觉神经束植入与血管束植入的成骨效果比较无明显差异,血管束植入组的成骨效果优于其它两组。结论利用感觉神经束植入的方法可以提高组织工程骨的成骨作用,而植入运动神经束却无此作用。 相似文献
26.
目的探讨经皮双针囊内注射类固醇治疗小儿孤立性骨囊肿的疗效. 方法 1996年1月~2004年1月,对28例小儿孤立性骨囊肿,在X线透视下,将2根细的骨穿针或腰穿针分别自囊腔顶部和底部刺入骨囊肿内,抽去囊液,冲洗囊腔后注入类固醇. 结果 27例随访10~62个月,平均28个月,无并发症发生.根据Chigira等X线骨囊肿愈合评价标准,Ⅳ级20例,Ⅲ级5例,Ⅱ例1例,Ⅰ级1例,治愈率92.6%(25/27).25例骨囊腔愈合时间3~10个月,平均4.5个月. 结论经皮双针囊腔内注射类固醇适合于小儿孤立性骨囊肿,简单,安全,治愈率高. 相似文献
27.
Torsion of noncircular beams results in warping of each cross section. When noncircular cross sections are constrained to remain plane, the resulting shear stress distribution is different from what Saint Venant torsion (with warping) would predict. This has practical implications to the stress analysis of plated long bones subjected to torsional loadings. Analyses in which warping is not allowed predict incorrect stress fields in the plate and bone and overpredict the amount of stress shielding associated with fracture plate fixation. 相似文献
28.
Borras Merce; Valdivielso Jose M.; Egido Ramon; Vicente de Vera Pilar; Bordalba Josep Ramon; Fernandez Elvira 《Nephrology, dialysis, transplantation》2006,21(3):789-791
29.
双头加压螺纹钉贴股骨距内固定治疗股骨颈骨折 总被引:8,自引:0,他引:8
在X光电视下采用双头加压螺纹钉贴股骨距内固定治疗新鲜股骨颈骨折42例,随访平均2.5年,其中16例随访3年以上,骨折愈合率95.2%,骨折不愈合并股骨头缺血性坏死率4.76%。认为加压螺纹钉贴股骨距内固定可使钉的受力由较大剪应力变为较大轴向力承受,减少骨折处的剪应力,并加压于骨折端能促进骨折愈合。具有操作简单、进钉准确、创伤小、固定牢靠、并发症少等优点。 相似文献
30.
Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal,bone-active drug ipriflavone 总被引:2,自引:0,他引:2
Hormone replacement therapy is the optimal therapeutic choice for postmenopausal syndrome. While low doses of estrogens (0.3 mg/day of conjugated estrogens) can counteract neurovegetative menopausal symptoms, higher doses (0.625 mg/day of conjugated estrogens) are required to prevent bone loss in postmenopausal women. Experimental and clinical studies have shown that ipriflavone, a non-hormonal isoflavone derivative, is effective in the prevention and treatment of postmenopausal osteoporosis. The aim of the present investigation was to evaluate the efficacy and toler-ability of ipriflavone and very low doses of equine conjugated estrogens on bone loss in early postmenopausal women. Eighty-three healthy postmenopausal women (50.3±0.7 years) were enrolled for this 1-year multicenter study. All subjects were randomly allocated to receive: double placebo (n=24; group A), placebo plus conjugated equine estrogens 0.30 mg/day (n=31; group B) or conjugated equine estrogens 0.30 mg/day plus oral ipriflavone 200 mg tris in die at meals (n=28; group C), according to a double-masked design. Among women who completed the treatment period (valid completers), those of group A showed a progressive decrease in forearm bone density (FBD; measured by dual photon absorptiometry) that reached 1.7% after 12 months. The women in group B maintained their FBD in the first 6 months of treatment but, at the end of the study, showed a bone loss of 1.4% compared with basal values. By contrast, women in group C showed a significant increase in FBD after 1 year of treatment (+5.6%;p<0.01). Bothvalid completers andintention to treat analyses revealed a significant difference (p<0.05) between group A and group C over the study period. None of the treatments produced significant changes of biochemical markers of bone turnover, while hot flushes and other climacteric symptoms were significantly reduced after the sixth month of treatment in women receiving estrogens. Adverse events were generally mild, and did not differ among the groups. The results of this study suggest that low doses of estrogens combined with ipriflavone could represent a new therapeutic approach to the treatment of the postmenopausal syndrome. 相似文献